Coding potential of the products of alternative splicing in human.
BACKGROUND
Analysis of the human genome has revealed that as much as an order of magnitude more of the genomic sequence is transcribed than accounted for by the predicted and characterized genes. A number of these transcripts are alternatively spliced forms of known protein coding genes; however, it is becoming clear that many of them do not necessarily correspond to a functional protein.


RESULTS
In this study we analyze alternative splicing isoforms of human gene products that are unambiguously identified by mass spectrometry and compare their properties with those of isoforms of the same genes for which no peptide was found in publicly available mass spectrometry datasets. We analyze them in detail for the presence of uninterrupted functional domains, active sites as well as the plausibility of their predicted structure. We report how well each of these strategies and their combination can correctly identify translated isoforms and derive a lower limit for their specificity, that is, their ability to correctly identify non-translated products.


CONCLUSIONS
The most effective strategy for correctly identifying translated products relies on the conservation of active sites, but it can only be applied to a small fraction of isoforms, while a reasonably high coverage, sensitivity and specificity can be achieved by analyzing the presence of non-truncated functional domains. Combining the latter with an assessment of the plausibility of the modeled structure of the isoform increases both coverage and specificity with a moderate cost in terms of sensitivity.
Dipartimento di Scienze Biochimiche, Sapienza Università di Roma, P.le A. Moro, 5 - 00185 Rome, Italy.
Guido
G
Leoni
Loredana
L
Le Pera
Fabrizio
F
Ferrè
Domenico
D
Raimondo
Anna
A
Tramontano
D017398:Alternative Splicing; D005786:Gene Expression Regulation; D006801:Humans; D013058:Mass Spectrometry; D054730:Protein Interaction Domains and Motifs / Q000235:genetics; D020033:Protein Isoforms / Q000737:chemistry / Q000235:genetics*; D020543:Proteome; D012680:Sensitivity and Specificity; D014158:Transcription, Genetic
D020033:Protein Isoforms; D020543:Proteome
Proteomics. 2010 Mar;10(6):1127-40
20077415
Science. 2008 Aug 15;321(5891):956-60
18599741
Nature. 2008 Nov 27;456(7221):470-6
18978772
Nat Methods. 2008 Jul;5(7):621-8
18516045
Trends Biochem Sci. 2005 Sep;30(9):515-21
16023350
BMC Genomics. 2006 Dec 27;7:325
17192196
Curr Protoc Bioinformatics. 2006 Oct;Chapter 5:Unit-5.6
18428767
Bioinformatics. 2005 Apr 1;21(7):951-60
15531603
Nat Genet. 2008 Dec;40(12):1413-5
18978789
Nucleic Acids Res. 2010 Jan;38(Database issue):D211-22
19920124
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5495-500
17372197
J Mol Biol. 2005 Feb 18;346(2):477-92
15670598
Nucleic Acids Res. 2009 Aug;37(14):4862-72
19528068
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
10592235
Bioinformatics. 2007 Jul 15;23(14):1834-6
17483506
Nucleic Acids Res. 2008 Feb;36(2):550-8
18055499
Nat Biotechnol. 2007 Jan;25(1):125-31
17195840
BMC Genomics. 2008 Oct 02;9:453
18831736
Nucleic Acids Res. 2010 Jan;38(Database issue):D557-62
19906699
Nucleic Acids Res. 2003 Jan 1;31(1):365-70
12520024
Genome Res. 2007 Feb;17(2):231-9
17189379
Nucleic Acids Res. 2003 Jul 1;31(13):3364-6
12824328
Genome Biol. 2008;9(11):R162
19017398
J Mol Recognit. 1995 Nov-Dec;8(6):334-44
9052974
Trends Genet. 2003 Mar;19(3):124-8
12615003
EMBO Rep. 2008 May;9(5):429-34
18451766